These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38233816)

  • 1. Role of thymosin α1 in restoring immune response in immunological nonresponders living with HIV.
    Chen C; Wang J; Xun J; Zhang X; Liu L; Song Z; Zhang R; Chen J; Lu H
    BMC Infect Dis; 2024 Jan; 24(1):97. PubMed ID: 38233816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot study of the safety and efficacy of thymosin alpha 1 in augmenting immune reconstitution in HIV-infected patients with low CD4 counts taking highly active antiretroviral therapy.
    Chadwick D; Pido-Lopez J; Pires A; Imami N; Gotch F; Villacian JS; Ravindran S; Paton NI
    Clin Exp Immunol; 2003 Dec; 134(3):477-81. PubMed ID: 14632754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced immune reconstitution with albuvirtide in HIV-infected immunological non-responders.
    Fan L; Hu Y; Li R; Ding J; Liu Y; Yu S; Hu M; Su R; Li Y; Yu A; Xie D; Zhao Q; Ma P
    Front Cell Infect Microbiol; 2024; 14():1397743. PubMed ID: 38975330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymosin Alpha-1 Has no Beneficial Effect on Restoring CD4+ and CD8+ T Lymphocyte Counts in COVID-19 Patients.
    Wang Z; Chen J; Zhu C; Liu L; Qi T; Shen Y; Zhang Y; Xu L; Li T; Qian Z; Steinhart CR; Lu H
    Front Immunol; 2021; 12():568789. PubMed ID: 34149679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The predictive role of CD4
    Li CX; Li YY; He LP; Kou J; Bai JS; Liu J; Tian B; Cao LJ; Wang KH; Kuang YQ
    BMC Immunol; 2019 Aug; 20(1):31. PubMed ID: 31455209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
    Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
    Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced thymic output is a major mechanism of immune reconstitution failure in HIV-infected patients after long-term antiretroviral therapy.
    Li T; Wu N; Dai Y; Qiu Z; Han Y; Xie J; Zhu T; Li Y
    Clin Infect Dis; 2011 Nov; 53(9):944-51. PubMed ID: 21960716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of TIM-3 expression on NK and T cell subsets in HIV immunological non-responders.
    de Kivit S; Lempsink LJ; Plants J; Martinson J; Keshavarzian A; Landay AL
    Clin Immunol; 2015 Jan; 156(1):28-35. PubMed ID: 25450337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased early activation of CD56dimCD16dim/- natural killer cells in immunological non-responders correlates with CD4+ T-cell recovery.
    Zhang QY; Zhang X; Su B; Liu LF; Yang XD; Tang B; Xia H; Ma P; Zhang T; Wu H
    Chin Med J (Engl); 2020 Nov; 133(24):2928-2939. PubMed ID: 33252378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between CD4
    Lu D; Zhang JB; Wang YX; Geng ST; Zhang Z; Xu Y; Li SY; Wang KH; Kuang YQ
    BMC Infect Dis; 2021 Aug; 21(1):742. PubMed ID: 34344350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raltegravir intensification shows differing effects on CD8 and CD4 T cells in HIV-infected HAART-suppressed individuals with poor CD4 T-cell recovery.
    Massanella M; Negredo E; Puig J; Puertas MC; Buzón MJ; Pérez-Álvarez N; Carrillo J; Clotet B; Martínez-Picado J; Blanco J
    AIDS; 2012 Nov; 26(18):2285-93. PubMed ID: 23018435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated dendritic cells and monocytes in HIV immunological nonresponders: HIV-induced interferon-inducible protein-10 correlates with low future CD4+ recovery.
    Stiksrud B; Aass HCD; Lorvik KB; Ueland T; Trøseid M; Dyrhol-Riise AM
    AIDS; 2019 Jun; 33(7):1117-1129. PubMed ID: 30789356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term and long-term clinical and immunological consequences of stopping antiretroviral therapy in HIV-infected patients with preserved immune function.
    Imaz A; Olmo M; Peñaranda M; Gutiérrez F; Romeu J; Larrousse M; Domingo P; Oteo JA; Curto J; Vilallonga C; Masiá M; López-Aldeguer J; Iribarren JA; Podzamczer D;
    Antivir Ther; 2013; 18(1):125-30. PubMed ID: 22805174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of PD-1 and Tim-3 markers of T-cell exhaustion is associated with CD4 dynamics during the course of untreated and treated HIV infection.
    Rallón N; García M; García-Samaniego J; Cabello A; Álvarez B; Restrepo C; Nistal S; Górgolas M; Benito JM
    PLoS One; 2018; 13(3):e0193829. PubMed ID: 29518102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1-specific T-cell responses and exhaustion profiles in people with HIV after switching to dual therapy vs. maintaining triple therapy based on integrase inhibitors.
    Muñoz-Muela E; Trujillo-Rodríguez M; Serna-Gallego A; Saborido-Alconchel A; Ruiz-Mateos E; López-Cortés LF; Gutiérrez-Valencia A
    Biomed Pharmacother; 2023 Dec; 168():115750. PubMed ID: 37871555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymosin Alpha 1 Reduces the Mortality of Severe Coronavirus Disease 2019 by Restoration of Lymphocytopenia and Reversion of Exhausted T Cells.
    Liu Y; Pan Y; Hu Z; Wu M; Wang C; Feng Z; Mao C; Tan Y; Liu Y; Chen L; Li M; Wang G; Yuan Z; Diao B; Wu Y; Chen Y
    Clin Infect Dis; 2020 Nov; 71(16):2150-2157. PubMed ID: 32442287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphopenia-induced proliferation of CD4 T-cells is associated with CD4 T-lymphocyte exhaustion in treated HIV-infected patients.
    Saidakova EV; Shmagel KV; Korolevskaya LB; Shmage NG; Chereshnev VA
    Indian J Med Res; 2018 Apr; 147(4):376-383. PubMed ID: 29998873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune recovery in acute and chronic HIV infection and the impact of thymic stromal lymphopoietin.
    Gelpi M; Hartling HJ; Thorsteinsson K; Gerstoft J; Ullum H; Nielsen SD
    BMC Infect Dis; 2016 Oct; 16(1):591. PubMed ID: 27769179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis A vaccination and immunological parameters in HIV-infected patients.
    Kourkounti S; Papaizos V; Leuow K; Kordosis T; Antoniou C
    Viral Immunol; 2013 Oct; 26(5):357-63. PubMed ID: 24044625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maraviroc as intensification strategy in HIV-1 positive patients with deficient immunological response: an Italian randomized clinical trial.
    Rusconi S; Vitiello P; Adorni F; Colella E; Focà E; Capetti A; Meraviglia P; Abeli C; Bonora S; D'Annunzio M; Di Biagio A; Di Pietro M; Butini L; Orofino G; Colafigli M; d'Ettorre G; Francisci D; Parruti G; Soria A; Buonomini AR; Tommasi C; Mosti S; Bai F; Di Nardo Stuppino S; Morosi M; Montano M; Tau P; Merlini E; Marchetti G
    PLoS One; 2013; 8(11):e80157. PubMed ID: 24244635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.